| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| B7-H5 | Human B7-H5 / Gi24 / VISTA Protein, His Tag (MALS & BLI verified) | Human | HEK293 | ![]() | MALSSDS-PAGE | $305.00 100ug | ||
| B7-H5 | Biotinylated Human B7-H5 / Gi24 / VISTA Protein, Avitag™,His Tag (BLI verified) | Human | HEK293 | ![]() | SDS-PAGE | $360.00 25ug | ||
| B7-H5 | Human B7-H5 / Gi24 / VISTA Protein, Mouse IgG2a Fc Tag, low endotoxin | Human | HEK293 | ![]() | SDS-PAGE | $310.00 100ug | ||
| B7-H5 | Human B7-H5 / Gi24 / VISTA Protein, Fc Tag | Human | HEK293 | ![]() | SDS-PAGE | $305.00 100ug | ||
| B7-H5 | Biotinylated Human B7-H5 / Gi24 / VISTA Protein, Fc,Avitag™ | Human | HEK293 | ![]() | SDS-PAGE | $360.00 25ug | ||
| B7-H5 | Rhesus macaque B7-H5 / Gi24 / VISTA Protein, His Tag | Rhesus macaque | HEK293 | ![]() | SDS-PAGE | $325.00 100ug | ||
| B7-H5 | Mouse B7-H5 / Gi24 / VISTA Protein, His Tag | Mouse | HEK293 | ![]() | SDS-PAGE | $360.00 100ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| CA-170 | CA-170; AUPM-170 | Phase 3 Clinical | Aurigene | Carcinoma, Non-Small-Cell Lung; Neoplasms; Solid tumours | Details |
| Solnerstotug | SNS-101; SNS-VISTA | Phase 2 Clinical | Sensei Biotherapeutics Inc | Breast Neoplasms; Carcinoma, Merkel Cell; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Esophageal Neoplasms; Head and Neck Neoplasms; Kidney Neoplasms; Melanoma; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Sarcoma; Solid tumours; Stomach Neoplasms; Thyroid Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms | Details |
| Trovostobart | KVA-12123; KVA-12.1 | Phase 2 Clinical | GigaGen Inc | Breast Neoplasms; Carcinoma; Colorectal Neoplasms; Esophageal Neoplasms; Head and Neck Neoplasms; Kidney Neoplasms; Lung Neoplasms; Melanoma; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Sarcoma; Solid tumours; Stomach Neoplasms; Thyroid Neoplasms; Uterine Neoplasms | Details |
| Onvatilimab | CI-8993; JNJ-61610588 | Phase 1 Clinical | Immunext Inc, Johnson & Johnson Innovative Medicine | Neoplasms; Solid tumours | Details |
| HMBD-002 | HMBD-002 | Phase 1 Clinical | Hummingbird Bioscience | Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Neoplasms; Solid tumours; Triple Negative Breast Neoplasms | Details |
| PMC-309 | PMC-309 | Phase 1 Clinical | Pharmabcine | Neoplasms; Solid tumours | Details |
| TBS-2025 | TBS-2025 | Phase 1 Clinical | Kintara Therapeutics Inc | Leukemia, Myeloid, Acute | Details |
| LFD-200 | LFD-200 | Phase 1 Clinical | Lifordi Immunotherapeutics Inc | Arthritis, Rheumatoid | Details |